Table 2.

Baseline demographics and clinical characteristics.

	Total (n = 80)	Non-PMI (n = 32)	PMI (n = 48)	P
Age	63.1 ± 9.8	62.1 ± 10.6	64.5 ± 9.8	0.358
Male	55 (68.8%)	22 (68.8%)	33 (68.8%)	1.000
Hypertension	48 (60.0%)	20 (62.5%)	28 (58.3%)	0.709
Diabetes	21 (26.3%)	6 (18.8%)	15 (31.3%)	0.213
Smoking history	28 (35.0%)	11 (34.4%)	17 (35.4%)	0.924
Prior PCI	18 (22.5%)	5 (15.6%)	1 3(27.1%)	0.229
Laboratory and auxiliary examinations
Creatinine [mg/dL]	77.5 ± 16.6	77.7 ± 16.6	77.4 ± 16.8	0.951
CK [U/L]	99.6 ± 53.6	114.5 ± 67.9	90.0 ± 39.8	0.228
CK-MB [U/L]	16.6 ± 7.4	16.5 ± 10.4	16.7 ± 4.7	0.195
hs-CRP [mg/L]	2.4 ± 4.3	1.5 ± 1.7	3.0 ± 5.4	0.502
White blood cell count [×109/L]	6.24 ± 1.63	5.96 ± 1.71	6.42 ± 1.57	0.230
Platelet [×109/L]	208.2 ± 55.6	207.1 ± 41.3	209.0 ± 63.7	0.818
Total cholesterol [mmol/L]	3.72 ± 0.91	3.54 ± 0.70	3,83 ± 1.01	0.260
LDL [mmol/L]	1.84 ± 0.79	1.72 ± 0.53	1.91 ± 0.92	0.584
Triglycerides [mmol/L]	1.84 ± 1.15	2.02 ± 1.45	1.73 ± 0.91	0.617
HDL [mmol/L]	1.11 ± 0.33	1.07 ± 0.31	1.14 ± 0.34	0.393
Lp(a) [mmol/L]	287.0 ± 339.6	229.1 ± 238.1	324.7 ± 389.8	0.407
HbA1c [%]	6.05 ± 0.80	6.08 ± 0.82	6.04 ± 0.79	0.823
Echocardiography
Left atrium [mm]	38.5 ± 3.8	39.7 ± 4.3	38.2 ± 3.4	0.475
LVEDD [mm]	46.1 ± 3.9	46.8 ± 3.9	45.7 ± 3.9	0.210
SPAP [mmHg]	32.5 ± 7.2	33.0 ± 7.4	32.1 ± 7.1	0.184
Ejection fraction [%]	64.6 ± 8.1	65.6 ± 2.9	63.9 ± 10.1	0.365

Data are shown as mean ± standard deviation or number (%). CK — creatine kinase; hs-CRP — high sensitive C-reactive protein; HDL — high density lipoprotein; LDL — low density lipoprotein; LVEDD — left ventricular end-diastolic diameter; Lp(a), lipoprotein (a); PMI — periprocedural myocardial injury; PCI — percutaneous coronary intervention; SPAP — systolic pulmonary arterial pressure